← Back to patent-cliff list
苯磺酸氨氯地平/他达拉非
Tier C — Watch / tradeAmlodipine Besylate/Tadalafil
韩美药品株式会社
Originator
2016
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：VDCCs、PDE5A
Brand：Amorafil
Indications (approved)：勃起功能障碍、高血压
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Amlodipine Besylate/Tadalafil?
Approved indications include: 勃起功能障碍, 高血压.
When does the Amlodipine Besylate/Tadalafil patent expire?
No public expiry year is available for Amlodipine Besylate/Tadalafil yet; this page updates once verified.
How do I get a quote for Amlodipine Besylate/Tadalafil intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24